NeuroOne Medical TechnologiesNMTC -0.66%39 Days Inventory is 146.01 as of Mar. 2026, which is 51% below its 10-year median of 296.88. GuruFocus rates NMTC with a GF Score™ of 39/100 and a GF Value™ of $6.60 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 786 Medical Devices & Instruments companies, NeuroOne Medical Technologies ranks better than 58.91% on this metric.
The historical rank and industry rank for NeuroOne Medical Technologies's Days Inventory or its related term are showing as below:
NMTC'
s Days Inventory Range Over the Past 10 Years
Min: 129.6 Med: 296.88 Max: 605.57
Current: 156.71
During the past 13 years, NeuroOne Medical Technologies's highest Days Inventory was 605.57. The lowest was 129.60. And the median was 296.88.
NMTC's Days Inventory is ranked better than 58.91% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.785
vs NMTC: 156.71
Inventory Turnover measures how fast the company turns over its inventory within a year.
NeuroOne Medical Technologies's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.62.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
NeuroOne Medical Technologies's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.74.
NeuroOne Medical Technologies (NAS:NMTC) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
NeuroOne Medical Technologies's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
NeuroOne Medical Technologies's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
NeuroOne Medical Technologies Days Inventory Related Terms
NeuroOne Medical Technologies Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NeuroOne Medical Technologies Days Inventory Chart
NMTC vs RDGL, TANAF, MODD: Days Inventory Comparison
For the Medical Devices subindustry, NeuroOne Medical Technologies's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NeuroOne Medical Technologies Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, NeuroOne Medical Technologies's Days Inventory distribution charts can be found below:
* The bar in red indicates where NeuroOne Medical Technologies's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NeuroOne Medical Technologies (NMTC) has a Days Inventory of 146.01 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on NeuroOne Medical Technologies and its competitors. This is 51% below median its historical median of 296.88. Over the past decade, NeuroOne Medical Technologies' Days Inventory has ranged from 129.60 to 605.57. According to the industry distribution chart, NeuroOne Medical Technologies ranks #323 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 41.1%.
Is NeuroOne Medical Technologies' Days Inventory too high?
NeuroOne Medical Technologies' current Days Inventory of 146.01 is 51% below median its 10-year median of 296.88. Over the past 10 years, this metric has ranged from a low of 129.60 to a high of 605.57. The Medical Devices & Instruments industry median Days Inventory is 179.79. NeuroOne Medical Technologies' value of 146.01 is 18.8% below this industry median. Based on the distribution chart, NeuroOne Medical Technologies ranks #323 out of 786 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, NeuroOne Medical Technologies has a GF Score™ of 39/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does NeuroOne Medical Technologies' Days Inventory compare to RDGL and TANAF?
According to the Medical Devices & Instruments industry distribution chart, NeuroOne Medical Technologies ranks #323 out of 786 companies for Days Inventory. This puts NeuroOne Medical Technologies in the upper half of its industry. The industry median Days Inventory is 179.79. NeuroOne Medical Technologies' value of 146.01 is 18.8% below this benchmark. Historically, NeuroOne Medical Technologies' own Days Inventory has ranged from 129.60 to 605.57 over the past decade. While the company's 10-year median is 296.88 vs. the industry median of 179.79, NeuroOne Medical Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.79, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NeuroOne Medical Technologies's current Days Inventory of 146.01 is 18.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on NeuroOne Medical Technologies and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NeuroOne Medical Technologies's current Days Inventory is 146.01, which is 51% below median its own 10-year median of 296.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NeuroOne Medical Technologies stock overvalued right now?
Based on GuruFocus' analysis, NeuroOne Medical Technologies (NMTC) is currently considered Possible Value Trap. The stock's GF Value™ is $6.60, compared to a current price of $3.01 — trading 54.4% below its estimated fair value. The current Days Inventory is 146.01, which is 51% below median its 10-year median of 296.88 and 18.8% below the Medical Devices & Instruments industry median of 179.79. NeuroOne Medical Technologies' overall GF Score™ is 39/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For NeuroOne Medical Technologies (NMTC), the current Days Inventory is 146.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NeuroOne Medical Technologies (NMTC) Overvalued in 2026?
Based on GuruFocus' analysis, NeuroOne Medical Technologies stock appears to be undervalued.
The current stock price of $3.01 is trading 54.4% below its estimated GF Value™ of $6.60.
GuruFocus considers NeuroOne Medical Technologies to be Possible Value Trap.
Key valuation signals for NMTC:
Days Inventory: 146.01 (51% below median its 10-year median of 296.88)
GF Value™: $6.60 vs. price of $3.01 (54.4% below fair value)
Industry Position: 18.8% below the Medical Devices & Instruments median (#323 of 786)
No single metric tells the full story. See the NMTC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NeuroOne Medical Technologies Business Description
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
39GF Score
Get the complete analysis for NMTC
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NMTC has been successfully added to your 
